• Friday, Sep 17, 2021
  • Last Update : 02:49 am

With US now in hand, BioNTech CEO looks for more vaccine production

  • Published at 12:49 pm December 12th, 2020
Ugur Sahin, CEO and co-founder of German biotech firm BioNTech
Ugur Sahin, CEO and co-founder of German biotech firm BioNTech, is interviewed by journalists in Marburg, Germany September 17, 2020 Reuters

The companies have not decided yet whether to evaluate a single-dose version of the vaccine, says Ugur Sahin

The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their Covid-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand.

"We need to solve the manufacturing challenge," Ugur Sahin told Reuters in an interview. "It is very clear that more doses are needed. And we are dealing with that question - how to produce more doses."

The companies have said they will produce up to 1.3 billion doses of the vaccine next year.

The US Food and Drug Administration (FDA) authorized the vaccine for emergency use on Friday, after Britain became the first country to begin deploying the shot outside of clinical trials earlier in the week.

Also Read - US FDA authorizes Pfizer Covid-19 vaccine for emergency use

Sahin said he expects the companies will receive conditional approval from the European Medicines Agency by the end of the month and can begin rolling out vaccine in European countries early next year.

One way he hopes to boost supply would be by bringing on earlier than projected the 750 million-dose-a-year plant BioNTech bought from Novartis AG in Marburg, Germany.

BioNTech had said it would begin making the vaccine there in the first half of 2021, and Sahin said they are working to get it up and running on an expedited timeline.

Also Read - US FDA authorizes Pfizer Covid-19 vaccine for emergency use

"The baseline plan is 1.3 billion doses," Sahin said. "And we are working on an extended plan. I can't tell you at the moment what is possible and how much we can expand the scale but we will try to do it significantly."

Supply of the vaccine will be limited at first in the United States, which has a population of roughly 330 million. The US government has ordered 100 million doses of the two-dose vaccine and could negotiate for more.

Also Read - Mexico approves emergency use of Pfizer's Covid-19 vaccine

Pfizer board member and former FDA commissioner Scott Gottlieb said in an interview with CNBC the company had offered to sell the United States more doses as recently as last month but had been turned down.

In data released this week, Pfizer and BioNTech said their vaccine began conferring some protection to recipients even before they received the second shot. It seemed to begin to show some efficacy around 12 days after the first shot.

Sahin said he was surprised by the data: "We know that the immune response is heavily boosted after the second dose."

He said the companies have not decided yet whether to evaluate a single-dose version of the vaccine.

"This will be a discussion that we will certainly have with our partners Pfizer," he said.

Facebook 79
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail